Meeting
2019 Gastrointestinal Cancers Symposium
Efficacy of three-drug induction chemotherapy followed by preoperative chemoradiation in patients with localized gastric adenocarcinoma (GAC).
Authors
Dilsa Mizrak Kaya
The University of Texas MD Anderson Cancer Center, Houston, TX
Dilsa Mizrak Kaya , Graciela M. Nogueras-Gonzalez , Prajnan Das , Mariela A. Blum Murphy , Fatemeh Ghazanfari Amlashi , Jane Elizabeth Rogers , Irene Thomas , Namita Shanbhag , Jeffrey H Lee , Manoop S. Bhutani , Brian Weston , Bruce D. Minsky , Aurelio Aurelio Matamoros Jr., Tara L. Sagebiel , Catherine E Devine , Jeannelyn Estrella , Brian D. Badgwell , Jaffer A. Ajani
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 106)
DOI
10.1200/JCO.2019.37.4_suppl.106
Abstract #
106
Poster Bd #
J16
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable esophagogastric junction adenocarcinoma: A retrospective study.
First Author: Toshiharu Hirose
Poster
2024 ASCO Annual Meeting
Neoadjuvant dual checkpoint inhibition followed by immune-chemoradiation in patients with resectable gastric adenocarcinoma.
First Author: Cindy M. Pabon
Poster
2023 ASCO Annual Meeting
Induction chemotherapy with nanosomal docetaxel lipid suspension (NDLS), cisplatin, and fluorouracil in patients with locally advanced head and neck squamous cell carcinoma.
First Author: Ghanashyam Biswas
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
First Author: Yuri Yoshinami